Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective

Subsequent surgical treatment or maintenance immunotherapy in stage III lung cancer patients achieving a favorable response following neoadjuvant immunotherapy: A matched retrospective cohort study from the surgical perspective

Abstract Background Current treatment strategies for advanced non‐small cell lung cancer (NSCLC) are highly individualized and subject to ongoing debates. In the era of immunotherapy, surgery assumes a critical role. The aim of this study was to investigate if subsequent surgical intervention, follo...

Full description

Bibliographic Details
Main Authors: Fuqiang Dai, Cong Chen, Guanyu Zhou, Xintian Wang, Longyong Mei, Nanzhi Luo, Wenjing Zhou, Tao Li, Bo Deng, Lunxu Liu, Yun Wang
Format: Article
Language:English
Published: Wiley 2024-04-01
Series:Thoracic Cancer
Subjects:
advanced stage III non‐small cell lung cancer
immunotherapy and chemotherapy
promising prognosis
surgery intervention
Online Access:https://doi.org/10.1111/1759-7714.15247

Internet

https://doi.org/10.1111/1759-7714.15247

Similar Items